W
Walvax Biotechnology Co Ltd
SZSE:300142
Walvax Biotechnology Co Ltd
SZSE:300142
Price:
12.57
CNY
-1.1%
Market Closed
Market Cap:
¥20.1B
Relative Value
The Relative Value of one Walvax Biotechnology Co Ltd stock under the Base Case scenario is 12.05 CNY. Compared to the current market price of 12.57 CNY, Walvax Biotechnology Co Ltd is Overvalued by 4%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
12.05
CNY
Overvaluation 4%
W
Multiples Across Competitors
Competitors Multiples
Walvax Biotechnology Co Ltd Competitors
Walvax Biotechnology Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
W
|
Walvax Biotechnology Co Ltd
SZSE:300142
|
20.1B CNY | 8.4 | 408.2 | -78.2 | -78.2 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
395.1B USD | 6.6 | 168.5 | 16.3 | 23.2 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
204.9B USD | 5.6 | 26.6 | 15.2 | 15.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
190B USD | 6.5 | 23.3 | 15.9 | 15.9 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD | 10.4 | 33 | 24.3 | 25.4 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 15.6 | 17.8 | |
| AU |
|
CSL Ltd
ASX:CSL
|
87.4B AUD | 3.9 | 20.2 | 13.5 | 16.9 | |
| NL |
|
argenx SE
XBRU:ARGX
|
41.9B EUR | 14 | 32.9 | 56 | 57.6 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
